Alexamorelin

Also known as: GHRP-4

Growth HormonePRECLINICAL

Clinical Status

Preclinical — discontinued from clinical development.

Mechanism of Action

A synthetic pentapeptide that acts as a growth hormone secretagogue by binding to ghrelin receptors. Stimulates GH release from the pituitary with moderate potency.

Dosing Defaults

Dose

100-200 mcg

Frequency

2-3x daily

Administration

Subcutaneous injection

Timing

Before bed (fasted)

Food

fasted

Duration

8-12 weeks

Dose range: 50-300 mcg per dose

Fasted administration optimizes GH pulse amplitude.

Side Effects

•Increased appetite
•Water retention
•Headache
•Flushing

Contraindications & Warnings

⚠Active malignancy

•Not medical advice
•Discontinued from development

Compare

Compare Alexamorelin with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Alexamorelin dose.

Open Calculator

Related Growth Hormone Peptides

Ipamorelin

PHASE 2

Growth Hormone

Selective GH secretagogue. Considered one of the safest GHRPs.

CJC-1295

PHASE 2

Growth Hormone

Synthetic GHRH analog that stimulates GH release from the pituitary.

CJC-1295 DAC

PHASE 2

Growth Hormone

Long-acting version of CJC-1295 with extended half-life via albumin binding.

Tesamorelin

FDA APPROVED

Growth Hormone

FDA-approved GHRH analog for visceral fat reduction in HIV lipodystrophy.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.